Molgradex
Sponsors
Savara ApS
Conditions
Autoimmune Pulmonary Alveolar ProteinosisAutoimmune pulmonary alveolar proteinosis
Phase 3
A randomized, double-blind, placebo-controlled clinical trial of once-daily inhaled molgramostim nebulizer solution in adult subjects with autoimmune pulmonary alveolar proteinosis (aPAP)
Active, not recruitingCTIS2024-511052-41-00
Start: 2021-05-10Target: 34Updated: 2025-11-10
An Open-label, Multicenter Clinical Study to Evaluate the Efficacy and Safety of Inhaled Molgramostim in Pediatric Subjects with Autoimmune Pulmonary Alveolar Proteinosis (aPAP)
RecruitingCTIS2024-512039-66-00
Start: 2025-09-11Target: 5Updated: 2025-08-13